Meeting ReportNeurosciences
In vivo imaging of brain muscarinic receptors with 18F-Flurobenzyl Dexetimide: First in human studies
Christopher Rowe, Brian Dean, Uwe Ackermann, Rachel Goh, Rodney Guzman, Richard Kanaan, Lee Chong, Vincent Dore, Svetlana Bozinovski, Colin Masters and Victor Villemagne
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1470;
Christopher Rowe
3Austin Hospital Melbourne Australia
Brian Dean
6University of Melbourne Melbourne Australia
Uwe Ackermann
1Molecular Imaging & Therapy Austin Health Melbourne Australia
Rachel Goh
1Molecular Imaging & Therapy Austin Health Melbourne Australia
Rodney Guzman
1Molecular Imaging & Therapy Austin Health Melbourne Australia
Richard Kanaan
2Psychiatry Austin Health Melbourne Australia
Lee Chong
1Molecular Imaging & Therapy Austin Health Melbourne Australia
Vincent Dore
4CSIRO Heidelberg Australia
Svetlana Bozinovski
1Molecular Imaging & Therapy Austin Health Melbourne Australia
Colin Masters
5Florey Institute Melbourne Australia
Victor Villemagne
1Molecular Imaging & Therapy Austin Health Melbourne Australia
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
In vivo imaging of brain muscarinic receptors with 18F-Flurobenzyl Dexetimide: First in human studies
Christopher Rowe, Brian Dean, Uwe Ackermann, Rachel Goh, Rodney Guzman, Richard Kanaan, Lee Chong, Vincent Dore, Svetlana Bozinovski, Colin Masters, Victor Villemagne
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1470;
In vivo imaging of brain muscarinic receptors with 18F-Flurobenzyl Dexetimide: First in human studies
Christopher Rowe, Brian Dean, Uwe Ackermann, Rachel Goh, Rodney Guzman, Richard Kanaan, Lee Chong, Vincent Dore, Svetlana Bozinovski, Colin Masters, Victor Villemagne
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1470;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.